Article metrics

Original research
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: December 2020 to June 2024

AbstractFullPdf
Dec 202059582
Jan 202116851640590
Feb 2021414406202
Mar 2021440437175
Apr 202126526388
May 2021325328114
Jun 202117217264
Jul 202116716950
Aug 202117817941
Sep 202113413550
Oct 202120020299
Nov 2021328329140
Dec 202113081318392
Jan 2022806777288
Feb 2022419413212
Mar 2022421412208
Apr 2022368361193
May 2022309300120
Jun 2022422407148
Jul 2022276264131
Aug 202225224594
Sep 2022348332144
Oct 2022397385142
Nov 2022376354162
Dec 202224322499
Jan 2023387373126
Feb 202332130588
Mar 2023372364137
Apr 2023271258110
May 2023269267109
Jun 202323623179
Jul 202320219573
Aug 202316115658
Sep 202325322857
Oct 2023277259109
Nov 202327223694
Dec 202325420995
Jan 202424720488
Feb 202415614478
Mar 2024171167124
Apr 2024207199100
May 202419118282
Jun 202414915173
Total14708142385628